Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?
Saved in:
| Title: | Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose? |
|---|---|
| Authors: | van Donge T; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com., Brizzi F; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com., Caruso A; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com., Fueth M; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com., Steiert B; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com. |
| Source: | Translational vision science & technology [Transl Vis Sci Technol] 2023 Apr 03; Vol. 12 (4), pp. 9. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Association for Research in Vision and Ophthalmology Country of Publication: United States NLM ID: 101595919 Publication Model: Print Cited Medium: Internet ISSN: 2164-2591 (Electronic) Linking ISSN: 21642591 NLM ISO Abbreviation: Transl Vis Sci Technol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
